PT - JOURNAL ARTICLE ED - , TI - â–¼Ezetimibe - a new cholesterol-lowering drug AID - 10.1136/dtb.2004.42965 DP - 2004 Sep 01 TA - Drug and Therapeutics Bulletin PG - 65--67 VI - 42 IP - 9 4099 - http://dtb.bmj.com/content/42/9/65.short 4100 - http://dtb.bmj.com/content/42/9/65.full SO - Drug Ther Bull2004 Sep 01; 42 AB - Relevant BNF section: 2.12Use of statin therapy is a key first-line approach in preventing coronary heart disease events and stroke in people at increased risk of developing such complications. â–¼Ezetimibe (Ezetrol - MSD-Schering-Plough), the first licensed azetidinone drug, is being promoted as an adjunct to statin therapy to achieve greater reductions in blood cholesterol concentrations than occur with a statin alone. Here we review ezetimibe and consider its place in clinical practice.